all
No description yet: the sentence for this tag has not been written. 5 records carry it: 5 people.
5 records
| Cancers | Other tags | ||||
|---|---|---|---|---|---|
Ching-Hon Pui Chair, Department of Oncology, St. Jude Children's Research Hospital · St. Jude Children's Research Hospital Led the St. Jude Total Therapy studies that cure over 90% of children with leukaemia without cranial radiation. | Acute lymphoblastic leukaemia | none | paediatric, st-jude | ||
Elias Jabbour Professor of Leukemia, MD Anderson Cancer Center · MD Anderson Cancer Center Leukaemia specialist who built chemotherapy-light regimens combining inotuzumab, blinatumomab and ponatinib for adult ALL. | Acute lymphoblastic leukaemia | none | immunotherapy, chemo-free | ||
Nicola Gökbuget Head of the GMALL Study Group; Professor of Medicine, University Hospital Frankfurt · University Cancer Center Frankfurt (UCT) Leads the German GMALL group and showed blinatumomab clears residual leukaemia in adults with ALL. | Acute lymphoblastic leukaemia | none | mrd, cooperative-group | ||
Stephen P. Hunger Chief, Division of Oncology, Children's Hospital of Philadelphia; Jeffrey E. Perelman Distinguished Chair in Pediatrics · Children's Hospital of Philadelphia Chaired the COG leukaemia committee through the era that pushed childhood ALL cure rates above 90%. | Acute lymphoblastic leukaemia | none | paediatric, cooperative-group | ||
Sumit Gupta Staff Oncologist and Senior Scientist, The Hospital for Sick Children (SickKids), Toronto · The Hospital for Sick Children (SickKids) Led COG AALL1731, which showed adding blinatumomab to chemotherapy improves survival for children with standard-risk leukaemia. | Acute lymphoblastic leukaemia | none | paediatric, immunotherapy |
